King Pharmaceuticals Inc. (KG)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

501 FIFTH ST BRISTOL, TN 37620

King Pharmaceuticals, Inc. (King) is a vertically integrated pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products and animal health products. King's branded prescription pharmaceuticals include neuroscience products (primarily pain medicines), hospital products and legacy brands, all of which are for use in humans. Its auto-injector business manufactures acute care medicines for use in humans that are delivered using an auto-injector. Its animal health business is focused on medicated feed additives (MFAs) and water-soluble therapeutics primarily for poultry, cattle and swine. King's business consists of four segments: a specialty-driven branded prescription pharmaceuticals business, global animal health business, Meridian auto-injector business, and royalties and other.

View SEC Filings from KG instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 1 1 0.0% (0.0%) (0.0%)
13F shares: 1 1 0.0%
% Ownership
New Positions:
Increased Positions
Closed Positions
Reduced Positions
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding KG (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding KG BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SQUICCIARINO JOSEPH CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2011-03-01 0

CARTER ERIC G CHIEF SCIENCE OFFICER

  • Officer
No longer subject to file 2011-03-01 0

BROUILLETTE FREDERICK JR CORPORATE COMPLIANCE OFFICER

  • Officer
No longer subject to file 2011-03-01 0

BAILEY JEFFREY ALLEN CHIEF COMMERCIAL OFFICER

  • Officer
No longer subject to file 2011-03-01 0

MARKISON BRIAN A PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2011-02-28 0

BRUCE ERIC J PRESIDENT, ANIMAL HEALTH

  • Officer
No longer subject to file 2011-02-28 0

MOYER CHARLES

  • Director
No longer subject to file 2011-02-28 0

GREETHAM ELIZABETH M

  • Director
No longer subject to file 2011-02-28 0

WOOD TED G

  • Director
No longer subject to file 2011-02-28 0

ELROD JAMES W CHIEF LEGAL OFFICER, A. SEC.

  • Officer
No longer subject to file 2011-02-15 0

JORDAN GREGORY D

  • Director
No longer subject to file 2011-01-31 0

SCHAFFER DERACE L

  • Director
No longer subject to file 2011-01-31 0

CRUTCHFIELD KEVIN S

  • Director
No longer subject to file 2011-01-31 0

SUPRAN BRYAN

  • Director
0 2011-01-31 0

PFIZER INC

PARKER TENNESSEE CORP.

  • 10% Owner
230,719,938 2011-01-31 0

GIORDANO DOUGLAS E.

  • Director
0 2011-01-31 0

LEPORE MATTHEW

  • Director
0 2011-01-31 0

PECK KRISTIN C

  • Director
0 2011-01-31 0

REID DAVID

  • Director
0 2011-01-31 0

ROOKER D GREGORY

  • Director
No longer subject to file 2010-11-29 0

DEAVENPORT EARNEST W JR

  • Director
No longer subject to file 2010-11-11 0

INCARNATI PHILIP A

  • Director
No longer subject to file 2010-10-07 0

ANDRZEJEWSKI STEPHEN J CHIEF COMMERCIAL OFFICER

  • Officer
171,929 2010-03-22 0

GREEN JAMES E EXEC VICE PRES CORP AFFAIRS

  • Officer
79,306 2009-03-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments